FDA Inspection 866095 — Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant)
The FDA completed an inspection of Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant) on Dec 20, 2013 in Wenzhou. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 20, 2013
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Wenzhou (China)